These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3201388)

  • 21. [Viskaldix in the treatment of arterial hypertension].
    Radeva N; Pasheva V; Nachev Ch
    Vutr Boles; 1982; 21(2):117-21. PubMed ID: 7101879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Should elderly hypertensive patients be treated with a beta-blocker-diuretic combination?].
    Böhmer F
    Z Gerontol; 1984; 17(2):89-92. PubMed ID: 6730636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viskaldix in the treatment of essential hypertension. A study on hospital out-patients.
    Cameron EG; Crowder D
    Practitioner; 1981 Apr; 225(1354):581-5. PubMed ID: 7279846
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of hypotensive drugs on serum levels of lipids and lipoproteins in humans].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1988 Oct; 43(44):1422-4. PubMed ID: 3252208
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term study of the antihypertensive effect of the pindolol and clopamide combination].
    Padovan GC; Gruppillo P; Masoni C; Tomaini MD
    G Ital Cardiol; 1981; 11(10):1456-9. PubMed ID: 7341315
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of viskaldix in the treatment of patients with hypertension].
    Mikunis RI; Klipatskiĭ AA; Monastyrskiĭ IuI; Kirichenko VI; Pshelutskiĭ FF
    Klin Med (Mosk); 1988 Oct; 66(10):62-4. PubMed ID: 3070156
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of bopindolol on lipids and platelet aggregation.
    Pintérová E; Kacerovský J; Zadák Z; Malý J; Pidrman V
    Cor Vasa; 1988; 30(5):352-60. PubMed ID: 3229118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK; Neuman SL
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood lipids and antihypertensive drugs. The Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Pharmacol; 1983; 14 Suppl 2():217-20. PubMed ID: 6632918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)].
    Faupel RP; Gotzen R
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1602-5. PubMed ID: 100301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemodynamic effects of hydrochlorothiazide, propranolol and a combination of pindolol and clopamide in patients with essential hypertension].
    Meza N; López H; Román O
    Rev Esp Cardiol; 1989 May; 42(5):304-8. PubMed ID: 2772366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lipid metabolism in hypertensive therapy. Measurements of electrolytes, lipids and lipoproteins in blood of normal and hypertensive individuals during repeated administration of Ebrantil].
    Mertz DP; Dittmann EC
    MMW Munch Med Wochenschr; 1983 May; 125(18):389-91. PubMed ID: 6406877
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.
    Ahaneku JE; Sakata K; Uranol T; Takada Y; Takada A
    Drugs Exp Clin Res; 2000; 26(4):119-23. PubMed ID: 11109511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glomerular filtrate, renal plasma flow, and sodium excretion in hypertensive patients before and following antihypertensive treatment with combination preparations].
    Habermann W; Stumpe KO; Krück F
    Med Klin; 1972 Oct; 67(42):1363-7. PubMed ID: 4629612
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E; Weidinger G
    MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fasting and postprandial lipids and lipoproteins during the chronic administration of antihypertensive drugs].
    Granados V; Ichazo S; Chávez J; Zamora J; Ochoa C; Cardoso G; Posadas C
    Arch Inst Cardiol Mex; 1994; 64(5):469-75. PubMed ID: 7840730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pindolol-clopamide combination in the treatment of arterial hypertension. Clinical study].
    Meilhac B; Bloch E; Zannier D; Metzger JP
    Therapie; 1983; 38(3):271-4. PubMed ID: 6612663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.